FTXH
FTXH
About First Trust Nasdaq Pharmaceuticals ETF
The First Trust Nasdaq Pharmaceuticals ETF is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before the Fund's fees and expenses, of an index called the Nasdaq US Smart Pharmaceuticals Index. The Fund seeks to replicate the holdings and weightings of the Nasdaq US Smart Pharmaceuticals Index so as to...
About First Trust Nasdaq Pharmaceuticals ETF
The First Trust Nasdaq Pharmaceuticals ETF is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before the Fund's fees and expenses, of an index called the Nasdaq US Smart Pharmaceuticals Index. The Fund seeks to replicate the holdings and weightings of the Nasdaq US Smart Pharmaceuticals Index so as to...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 ARWR | Arrowhead Pharmaceuticals, Inc. | 0.00% | - | $267.56K |
 ELAN | Elanco Animal Health Incorporated | 0.00% | 23.42K | $233.15K |
 JAZZ | Jazz Pharmaceuticals plc | 0.00% | 3.99K | $525.05K |
 JNJ | Johnson & Johnson | 0.00% | 6.94K | $1.54M |
 KRYS | Krystal Biotech, Inc. | 0.00% | 440 | $149.79K |
 PRGO | Perrigo Company plc | 0.00% | 5.20K | $71.46K |
 PTCT | PTC Therapeutics, Inc. | 0.00% | 1.43K | $363.72K |
 PTGX | Protagonist Therapeutics, Inc. | 0.00% | - | $125.16K |
 REGN | Regeneron Pharmaceuticals, Inc. | 0.00% | 819 | $921.93K |
 VRTX | Vertex Pharmaceuticals Incorporated | 0.00% | 165 | $816.28K |
 VTRS | Viatris Inc. | 0.00% | 62.04K | $778.46K |
 ZTS | Zoetis Inc. | 0.00% | 3.42K | $529.57K |
 LGND | Ligand Pharmaceuticals Incorporated | 0.00% | - | $110.98K |
 LLY | Eli Lilly and Company | 0.00% | 622 | $997.28K |
 RYTM | Rhythm Pharmaceuticals, Inc. | 0.00% | - | $88.38K |
 BBIO | BridgeBio Pharma, Inc. | 0.00% | - | $128.71K |
 BIIB | Biogen Inc. | 0.00% | 4.08K | $914.74K |
 BMRN | BioMarin Pharmaceutical Inc. | 0.00% | 2.81K | $236.10K |
 BMY | Bristol-Myers Squibb Company | 0.00% | 19.21K | $1.58M |
 AMRX | Amneal Pharmaceuticals, Inc. | 0.00% | 15.23K | $163.14K |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States
Ireland
NetherlandsSECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States Ireland NetherlandsHoldings (Top 20)
ARWR
Arrowhead Pharmaceuticals, Inc.
ELAN
Elanco Animal Health Incorporated
JAZZ
Jazz Pharmaceuticals plc
JNJ
Johnson & Johnson
KRYS
Krystal Biotech, Inc.
PRGO
Perrigo Company plc
PTCT
PTC Therapeutics, Inc.
PTGX
Protagonist Therapeutics, Inc.
REGN
Regeneron Pharmaceuticals, Inc.
VRTX
Vertex Pharmaceuticals Incorporated
VTRS
Viatris Inc.
ZTS
Zoetis Inc.
LGND
Ligand Pharmaceuticals Incorporated
LLY
Eli Lilly and Company
RYTM
Rhythm Pharmaceuticals, Inc.
BBIO
BridgeBio Pharma, Inc.
BIIB
Biogen Inc.
BMRN
BioMarin Pharmaceutical Inc.
BMY
Bristol-Myers Squibb Company
AMRX
Amneal Pharmaceuticals, Inc.